Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States

Muscle Nerve. 2015 May;51(5):635-7. doi: 10.1002/mus.24608. Epub 2015 Mar 31.

Authors

Ted M Burns¹, Donald B Sanders, Henry J Kaminski, Gil I Wolfe, Pushpa Narayanaswami, Jurgen Venitz

Affiliation

¹ University of Virginia, Department of Neurology, Charlottesville, Virginia, USA.

PMID: 25704880
DOI: 10.1002/mus.24608

No abstract available

Publication types

Editorial

MeSH terms

Humans
Immunosuppressive Agents / therapeutic use
Insurance Coverage / statistics & numerical data
Myasthenia Gravis / drug therapy*
Myasthenia Gravis / epidemiology*
Mycophenolic Acid / analogs & derivatives*
Mycophenolic Acid / therapeutic use
Off-Label Use / statistics & numerical data
Treatment Outcome
United States / epidemiology

Substances

Immunosuppressive Agents
Mycophenolic Acid